Northrop Grumman Corporation filings document formal disclosures for an NYSE-listed aerospace and defense contractor with common stock trading under NOC. Recent 8-K reports furnish quarterly and annual earnings releases, summarize operating results and awards, and record material events such as director elections, officer transitions, compensation actions and credit-facility agreements.
The company's proxy materials describe board structure, committee assignments, executive compensation and annual meeting governance. Its financing disclosures cover senior unsecured revolving credit arrangements, commercial paper support, covenants, events of default and capital-structure terms relevant to the company's defense and space systems operations.
Northrop Grumman executive Benjamin R. Davies, Corporate Vice President and President of Defense Systems, reported several stock transactions. He sold 2,189.04 shares of common stock in an open‑market sale at a weighted average price of $719.61 per share, leaving 151 shares held directly.
On the prior day, 274 restricted stock rights were exercised into the same number of common shares, and 123 shares were withheld at $701.12 per share to cover tax obligations. Davies now holds 6,444 restricted stock rights that are scheduled to vest in stages between 2026 and 2029.
Northrop Grumman executive Robert J. Fleming reported equity award activity involving restricted stock rights and common shares. On 2/17/26, 264 Restricted Stock Rights were exercised, issuing 264 shares of common stock at a stated price of $0.0000 per share, reflecting the vesting of prior awards. In a related tax-withholding transaction, 85 common shares were disposed of at $701.12 per share to cover tax obligations, rather than through an open-market sale.
Following these transactions, Fleming directly held 2,619.03 shares of Northrop Grumman common stock. He also held 6,513 Restricted Stock Rights, which include grants under the company’s long-term incentive plans scheduled to vest on future dates.
Northrop Grumman corporate vice president, controller and chief accounting officer Michael A. Hardesty reported multiple share transactions on February 17, 2026. He acquired 538 Restricted Stock Rights that converted into 538 common shares at no cost upon vesting, then disposed of 243 shares to cover taxes and sold 715.94 shares in an open-market transaction at $700.63 per share, leaving him with 2,672.29 common shares directly owned. Footnotes note these shares vested from awards granted under the company’s long-term incentive stock plans and that additional Restricted Stock Rights remain scheduled to vest in later years.
Northrop Grumman executive Thomas H. Jones, CVP & President Aeronautics Systems, reported equity award activity tied to long-term incentives. On February 17, 2026, 2,152 Restricted Stock Rights (RSRs) vested and converted into an equivalent number of common shares at no exercise price under prior awards.
In connection with this vesting, 1,005 common shares were disposed of at $701.12 per share to cover tax obligations through share withholding, rather than an open-market sale. After these transactions, Jones directly held 11,204.715 common shares, plus 6,513 RSRs scheduled to vest between 2027 and 2029 under the company’s long-term incentive plans.
Northrop Grumman Chair, CEO and President Kathy J. Warden exercised 10,760 Restricted Stock Rights, receiving the same number of common shares at a stated price of $0.00 per share upon vesting on February 17, 2026. To cover tax obligations, 4,857 common shares were disposed of at $701.12 per share through a tax-withholding transaction, leaving her with 196,680.56 directly owned common shares after these transactions. The Restricted Stock Rights and shares were granted under the company’s long-term incentive stock plans and vest on specified future dates.
Northrop Grumman corporate VP and general counsel Kathryn G. Simpson reported several equity transactions in company stock. On February 17, 2026 she exercised 387 Restricted Stock Rights, receiving 387 common shares at a stated price of $0 per share. Of these, 193 shares were disposed of at $701.12 per share to cover tax obligations, and 779 shares were sold in an open-market transaction at $702.56 per share under a Rule 10b5-1 trading plan adopted on February 28, 2025. After these transactions, she directly held 1,068.39 common shares.
Northrop Grumman executive Roshan S. Roeder, CVP & President of Mission Systems, reported a mix of equity award exercises and share disposals. On February 17, 2026, she exercised 2,017 Restricted Stock Rights, receiving an equal number of common shares at a stated price of $0.00 per share.
To cover tax obligations, 992 common shares were disposed of at $701.12 per share, and an additional 318 common shares were sold in the open market at $702.56 per share under a Rule 10b5-1 trading plan adopted on October 30, 2025. After these transactions, she directly held 4,619.39 common shares and 6,513 Restricted Stock Rights, alongside 115.9291 common shares held indirectly in the Northrop Grumman Savings Plan.
Northrop Grumman-related reporting person Michael A. Hardesty reported sales of company common stock. The filing lists proposed sales of $550,410.63 for 784 shares on 02/13/2026 and $501,609.04 for 716 shares on 02/17/2026. The record also references restricted stock vesting dated 02/17/2026 tied to compensation.
NOC filer submitted a Rule 144 notice to sell 512 shares of common stock. The filing lists the 512 shares as Restricted Stock Vesting from 02/17/2026 under compensation.
It also discloses prior sales by Roshan Roeder of 84 shares on 12/09/2025 and 318 shares on 02/17/2026.
NOC reported a Form 144 filing showing a sale of securities by an insider. The filing shows 779 shares of common stock sold on 02/17/2026 for an aggregate of $547,294.24, with the disposition tied to restricted stock vesting.